全文获取类型
收费全文 | 88529篇 |
免费 | 6725篇 |
国内免费 | 2179篇 |
专业分类
耳鼻咽喉 | 607篇 |
儿科学 | 1915篇 |
妇产科学 | 1221篇 |
基础医学 | 12621篇 |
口腔科学 | 1254篇 |
临床医学 | 5510篇 |
内科学 | 14715篇 |
皮肤病学 | 1386篇 |
神经病学 | 5708篇 |
特种医学 | 2113篇 |
外国民族医学 | 294篇 |
外科学 | 7192篇 |
综合类 | 11202篇 |
现状与发展 | 7篇 |
一般理论 | 2篇 |
预防医学 | 8819篇 |
眼科学 | 789篇 |
药学 | 11914篇 |
8篇 | |
中国医学 | 4157篇 |
肿瘤学 | 5999篇 |
出版年
2023年 | 1146篇 |
2022年 | 2399篇 |
2021年 | 2922篇 |
2020年 | 2465篇 |
2019年 | 3704篇 |
2018年 | 3596篇 |
2017年 | 2822篇 |
2016年 | 2365篇 |
2015年 | 2797篇 |
2014年 | 7596篇 |
2013年 | 6549篇 |
2012年 | 5857篇 |
2011年 | 6582篇 |
2010年 | 7292篇 |
2009年 | 6086篇 |
2008年 | 3927篇 |
2007年 | 2729篇 |
2006年 | 2334篇 |
2005年 | 2156篇 |
2004年 | 1927篇 |
2003年 | 1602篇 |
2002年 | 1256篇 |
2001年 | 1168篇 |
2000年 | 1009篇 |
1999年 | 887篇 |
1998年 | 721篇 |
1997年 | 692篇 |
1996年 | 588篇 |
1995年 | 541篇 |
1994年 | 465篇 |
1993年 | 386篇 |
1992年 | 305篇 |
1991年 | 300篇 |
1990年 | 265篇 |
1989年 | 230篇 |
1988年 | 205篇 |
1987年 | 191篇 |
1985年 | 803篇 |
1984年 | 1103篇 |
1983年 | 787篇 |
1982年 | 851篇 |
1981年 | 798篇 |
1980年 | 765篇 |
1979年 | 705篇 |
1978年 | 577篇 |
1977年 | 491篇 |
1976年 | 643篇 |
1975年 | 529篇 |
1974年 | 497篇 |
1973年 | 448篇 |
排序方式: 共有10000条查询结果,搜索用时 48 毫秒
91.
Prevalence of H pylori associated 'high risk gastritis' for development of gastric cancer in patients with normal endoscopic findings 总被引:1,自引:0,他引:1
Andreas Leodolter Matthias P Ebert Ulrich Peitz Kathlen Wolle Stefan Kahl Peter Malfertheiner 《World journal of gastroenterology : WJG》2006,(34)
INTRODUCTION H pylori infection is an established risk factor for development of gastric cancer[1,2]. According to the model of carcinogenesis of the intestinal type adenocarcinoma proposed by Correa, the multi-step development starts from the condition o… 相似文献
92.
Outcomes at 3 years of a prospective pilot study of Campath-1H and sirolimus immunosuppression for renal transplantation 总被引:2,自引:0,他引:2
Rolf N. Barth Christina A. Janus Christine A. Lillesand Nancy A. Radke John D. Pirsch Bryan N. Becker Luis A. Fernandez L. Thomas Chin Yolanda T. Becker Jon S. Odorico Anthony M. D''Alessandro Hans W. Sollinger Stuart J. Knechtle 《Transplant international》2006,19(11):885-892
Campath-1H (alemtuzumab) induction was used for renal transplantation in combination with sirolimus as immunosuppression. We previously reported a high (28%) rate of early rejection with this regimen, and now report 3-year outcomes. Twenty-nine patients were recipients of either deceased donor or non-HLA (Human Leukocyte Antigen) identical living donor primary renal allografts. Clinical parameters including infection, malignancy, kidney function, and kidney histology were followed prospectively for 3 years. Three-year cumulative graft and patient survival were 96% and 100%, respectively. Twenty patients were maintained on steroid-free immunosuppressive regimens, and 15 patients were maintained on monotherapy for immunosuppression (12 on sirolimus). No serious infectious complications were observed and two patients developed basal cell skin cancer. The 3-year results of our initial pilot study demonstrate good graft (96%) and patient (100%) outcomes. Campath-1H induction has yielded a high proportion of patients maintained on immunosuppressive monotherapy (57%) without serious infectious- and no malignancy-related complications. The reported regimen yielded novel insights into both Campath-1H and sirolimus therapy in renal transplantation. Because of the higher incidence of early rejection, we recommend a modified strategy of immunosuppression including a brief course of a calcineurin inhibitor. 相似文献
93.
nm23-H1基因转染对人胆管癌细胞系QBC939体外浸润能力的影响 总被引:1,自引:0,他引:1
目的:探讨nm23-H1基因转染对人胆管癌细胞系QBC939体外浸润能力的影响。方法:将含有全长nm23-H1 cDNA的真核表达载体通过脂腩体法转染人胆管癌细胞系。结果:转染成功的QBC939细胞,其nm23-Hl基因的mRNA、蛋白表达明显增加,转染nm23-H1基因的胆管癌细胞体外浸润能力下降,穿越matrigel的细胞数明显低于亲本QBC939细胞,代表浸润能力的IV型胶原酶(MMP-9)分泌量下降。结论:nm23-Hl基因可以抑制胆管癌细胞的体外浸润能力。 相似文献
94.
报道新化合物A-失碳-17β-羟基-17α-乙炔基-Δ3(5),9(10)-雌甾二烯-2-酮2的合成。文中探讨了用炔钾粗品对A-失碳-Δ3(5),9(10)-雌甾二烯-2,17-二酮1和A-失碳-6β,19-环氧-Δ3-雄甾-2,17-二酮3的选择性炔化,分别得标题化合物2(44%)及A-失碳-17β-羟基-17α-乙炔基-6β,19-环氧-Δ3雄甾-2-酮4(65%),4经还原性破开环氧、去羟甲基和去醋酰氧基合成了标题化合物2。四步总收率为34%。 相似文献
95.
Acute Immobilization Stress and Intraventricular Injection of CRF Suppress Naloxone-Induced LH Release in Ovariectomized Estrogen-Primed Rats 总被引:1,自引:0,他引:1
Tatsuo Akema Atsuhiko Chiba Reiji Shinozaki Morihiro Oshida Fukuko Kimura & Jun-ichi Toyoda 《Journal of neuroendocrinology》1996,8(8):647-652
The present study was undertaken to evaluate the role and possible interaction of the endogenous opioid peptide (EOP) and corticotropin-releasing factor (CRF) in the acute stress-induced suppression of gonadotropin secretion in ovariectomized estrogen-primed rats. An intravenous (i.v.) injection of naloxone (10 or 20 mg/kg), an EOP antagonist, significantly elevated serum luteinizing hormone (LH) levels within 10 min in non-stressed animals. The naloxone-induced LH release was completely eliminated when tested 30 min after the onset of acute immobilization. In a subsequent study, it was found that suppression of the naloxone-induced LH release occurred as early as 5 min after the stress onset, and was still evident 60 min after the end of a 30-min period of immobilization. The effect of naloxone was restored 3 h after liberation of the animal from the 30-min immobilization. An intraventricular (i.c.v.) injection of CRF (1 or 5 μg) also significantly suppressed, in a dose-related manner, the effect of a subsequent i.v. injection of naloxone. However, an i.c.v. injection of α -helical CRF(9-41) (25 or 50 μg), a CRF antagonist, prior to immobilization, could not interfere with the suppressive effect of stress on naloxone-induced LH release. These results suggest that both acute immobilization stress and CRF can inhibit the LH secretory activity without mediation by EOP neurons. However, the stress-related suppression may involve non-CRF mechanism(s). 相似文献
96.
Regulations evolve and risks management becomes one of the biomedical engineers' preoccupations. Thus, risks are various, and consequently it is difficult to identify, to manage and to bring them under control. Furthermore, regulations exist for sectors like healthcare technology monitoring, but it is not the same thing for instance for the risks linked to the maintenance. Thus regulation in the sector of maintenance evolves and the decree of the 1st July law of health safety is going to modify the biomedical environment. The goal of this work is to study the tools and the methods of risks management that have been used for several years in the industrial field and to use them for some biomedical equipment like monitors or IV pumps. These methods adapted to these equipment will allow us to determine some appropriate rules of maintenance. 相似文献
97.
目的:为设计维甲酸治疗神经母细胞瘤可能的有效方案,本文对9-顺式维甲酸(9-cis retinoic acid,9-cisRA)体外诱导分化神经母细胞瘤细胞(SK-N-SH)作用进行了研究。方法:SK-N-SH细胞经9-cisRA处理后,采用相差显微镜,神经纤维银染法,透射电镜观察等手段。观察9-cisRA对细胞生长的影响。结果:9-cisRA作用SK-N-SH细胞7d后,细胞形态发生变化;12d时出现神经原性表型,多个细胞形成“神经节”,节间形成粗而长的类神经纤维;尼氏小体和银染法亦证明细胞产生显著分化,透射电镜观察结果表明,9-cisRA对该细胞有分化作用。却无明显凋亡诱导作用。结论:9-cisRA对神经母细胞瘤细胞体外能产生明显诱导分化作用。 相似文献
98.
肝细胞癌SCT表现和相关基因表达的初步研究 总被引:1,自引:0,他引:1
目的 探讨肝细胞癌细胞中nm2 3 H1基因和C erbB 2基因的表达和其与SCT表现的关系。方法 对 3 6例经手术病理证实且行螺旋CT动、静脉双期增强扫描的肝细胞癌病例 ,观察其SCT表现特征 ,如包膜、子灶、门静脉癌栓、肝门淋巴结转移、肿瘤的大小和强化特征。用免疫组织化学的方法检测癌组织中nm2 3 H1基因和C erbB 2基因的表达情况。结果 肝细胞癌细胞中 ,nm2 3 H1阳性 2 1例 ,阳性率为 5 8.3 % ,转移高危组 (子灶、门脉癌栓、肝门淋巴结转移 )nm2 3 H1基因的表达低于转移低危组 (P <0 .0 5 ) ;C erbB 2基因阳性 2 2例 ,阳性率为 71.1% ,C erbB 2基因的表达在中等大小肝癌组表达高于小肝癌组和大肝癌组 (P <0 .0 5 )。结论 肝细胞癌的SCT表现与nm2 3 H1和C erbB 2基因的表达有一定关系 相似文献
99.
ASSOCIATION OF PLASMA HOMOCYSTEINE LEVEL AND N^5,N^10—METHYLENETETRAHYDROFOLATE REDUCTASE GENE POLYMORPHISM WITH CEREBRAL INFARCTION 总被引:5,自引:1,他引:4
OBJECTIVE: To investigate the relationship of plasma homocysteine (Hcy) level to stroke and genetic factor to elevated plasma Hcy level. METHODS: The plasma Hcy level was measured by capillary electrophoresis-ultraviolet detection and the gene polymorphism of N5,N10-methylenetetrahydrofolate reductase (MTHFR) was studied with PCR-RFLP assay in 43 patients with cortical cerebral infarction and 42 healthy control. RESULTS: The plasma Hcy level of the patients (19.3 +/- 6.0 micromol/L) was markedly higher than that of the controls (13.7 +/- 5.4 micromol/L) (t = 4.16, P < 0.001). There are 3 genotypes, C/C, C/T and T/T, about base-variation of MTHFR gene at locus 677. The plasma Hcy level of the subjects with T/T genotype was higher than that of subjects with other genotypes. However, the frequencies of each genotype and allele were not significantly different between the patients and the controls. CONCLUSIONS: The elevated plasma Hcy level is a risk factor for atherothrombotic cerebral infarction, and is related to the C-->T mutation at locus 677 of MTHFR gene. 相似文献
100.
《Journal of labelled compounds & radiopharmaceuticals》2005,48(9):693-700
[(1R)‐endo]‐(+)‐3‐bromocamphor was dehalogenated with tritium gas to [3‐3H]camphor and via [3‐3H]phenylborneol converted to [3‐3H]deramciclane isolated as the fumarate salt (specific activity 51.8 GBq/mmol). This three step synthesis from [3‐3H]camphor gave an overall yield of 22%. Benzyloxy‐acetic acid methyl ester was reduced with sodium‐borotritide to 2‐benzyloxy‐ethanol‐[1‐3H], and through a four step procedure was converted to 2‐dimethylaminoethyl‐[2‐3H] chloride. The latter was condensed with the sodium derivative of 2‐phenylborneol giving rise to [2‐dimethylamino‐[2‐3H]ethoxy]deramciclane isolated as the fumarate (specific activity 8.177 GBq/mmol). This six step synthesis from [3H]NaBH4 gave an overall yield of 6%. Copyright © 2005 John Wiley & Sons, Ltd. 相似文献